You just read:

Realm Therapeutics Announces Publication of Pre-Clinical Study Demonstrating Comparable Activity of PR022 and Topical Tofacitinib in the Treatment of Atopic Dermatitis

News provided by

Realm Therapeutics

Jul 10, 2018, 07:00 ET